The Oxford vaccine has unique advantages, as does Pfizer’s. Using both is Australia’s best strategy
The best approach for protecting everyone’s health will require us to provide different vaccines to different people according to need and availability.
Study shows meaningful lockdown activity is more satisfying than busyness
With much of the world practicing varying degrees of social distancing and lockdown, researchers have been investigating the key to happiness in isolation.
New findings speed progress towards affordable gene therapy
In a promising advance for affordable, personalised medicine, researchers have used metal-organic frameworks to successfully deliver the genetic snipping tool CRISPR/Cas9 into human cancer cells.
90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data
Early analysis suggests this vaccine has an efficacy of over 90%. So if you took ten people who were going to get sick from COVID-19 and vaccinated them, only one out of ten would now get sick.